{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:16:35Z","timestamp":1783397795574,"version":"3.54.6"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ctro.2026.101194","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:58:59Z","timestamp":1779429539000},"page":"101194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["MESORECT : Influence of bladder depletion on mesorectal movements during radiation therapy of locally advanced rectal cancers: a prospective comparative study"],"prefix":"10.1016","volume":"59","author":[{"given":"Joly","family":"Alexandre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanc-Lapierre","family":"Audrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llagostera","family":"Camille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Denmat","family":"Dominique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guimas","family":"Valentine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rio","family":"Emmanuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libois","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101194_b0005","unstructured":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries - Bray - 2024 - CA: A Cancer Journal for Clinicians - Wiley Online Library [Internet]."},{"issue":"4","key":"10.1016\/j.ctro.2026.101194_b0010","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.dld.2017.01.152","article-title":"Rectal cancer: French Intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)","volume":"49","author":"G\u00e9rard","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ctro.2026.101194_b0015","unstructured":"Benson AB, Venook AP, Al-Hawary MM, Azad N, Chen YJ, Ciombor KK, et al. Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20(10):1139\u201167."},{"key":"10.1016\/j.ctro.2026.101194_b0020","doi-asserted-by":"crossref","unstructured":"Yeo SG, Kim MJ, Kim DY, Chang HJ, Kim MJ, Baek JY, et al. Patterns of failure in patients with locally advanced rectal cancer receiving pre-operative or post-operative chemoradiotherapy. Radiat Oncol. 2013;8(1):114.","DOI":"10.1186\/1748-717X-8-114"},{"key":"10.1016\/j.ctro.2026.101194_b0025","doi-asserted-by":"crossref","unstructured":"Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1(8496):1479\u201182.","DOI":"10.1016\/S0140-6736(86)91510-2"},{"issue":"6","key":"10.1016\/j.ctro.2026.101194_b0030","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jso.23198","article-title":"Failure patterns correlate with the tumor response after preoperative chemoradiotherapy for locally advanced rectal cancer","volume":"106","author":"Lim","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ctro.2026.101194_b0035","doi-asserted-by":"crossref","unstructured":"G\u00e9rard A, Buyse M, Nordlinger B, Loygue J, P\u00e8ne F, Kempf P, et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg. 1988;208(5):606\u201114.","DOI":"10.1097\/00000658-198811000-00011"},{"key":"10.1016\/j.ctro.2026.101194_b0040","doi-asserted-by":"crossref","unstructured":"Cedermark B, Johansson H, Rutqvist LE, Wilking N. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer. 1995;75(9):2269\u201175.","DOI":"10.1002\/1097-0142(19950501)75:9<2269::AID-CNCR2820750913>3.0.CO;2-I"},{"key":"10.1016\/j.ctro.2026.101194_b0045","doi-asserted-by":"crossref","unstructured":"Martling A, Holm T, Johansson H, Rutqvist LE, Cedermark B, Stockholm Colorectal Cancer Study Group. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer. 2001;92(4):896\u2011902.","DOI":"10.1002\/1097-0142(20010815)92:4<896::AID-CNCR1398>3.0.CO;2-R"},{"key":"10.1016\/j.ctro.2026.101194_b0050","doi-asserted-by":"crossref","unstructured":"Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol. 2005;23(24):5644\u201150.","DOI":"10.1200\/JCO.2005.08.144"},{"issue":"3","key":"10.1016\/j.ctro.2026.101194_b0055","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1470-2045(17)30086-4","article-title":"Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial","volume":"18","author":"Erlandsson","year":"2017","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.ctro.2026.101194_b0060","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1470-2045(15)00004-2","article-title":"Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial","volume":"16","author":"Garcia-Aguilar","year":"2015","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101194_b0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2026.101194_b0070","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101194_b0075","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/SLA.0000000000003471","article-title":"Total neoadjuvant therapy in rectal cancer: a systematic review and meta-analysis of treatment outcomes","volume":"271","author":"Petrelli","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.ctro.2026.101194_b0080","doi-asserted-by":"crossref","unstructured":"Kasi A, Abbasi S, Handa S, Al-Rajabi R, Saeed A, Baranda J, et al. Total neoadjuvant therapy vs standard therapy in locally advanced rectal cancer: a systematic review and meta-analysis. JAMA Netw Open. 2020;3(12):e2030097.","DOI":"10.1001\/jamanetworkopen.2020.30097"},{"key":"10.1016\/j.ctro.2026.101194_b0085","doi-asserted-by":"crossref","unstructured":"Cercek A, Roxburgh CSD, Strombom P, Smith JJ, Temple LKF, Nash GM, et al. Adoption of total neoadjuvant therapy for locally advanced rectal cancer. JAMA Oncol. 2018;4(6):e180071.","DOI":"10.1001\/jamaoncol.2018.0071"},{"key":"10.1016\/j.ctro.2026.101194_b0090","doi-asserted-by":"crossref","unstructured":"Conroy T, Castan F, Etienne PL, Rio E, Mesgouez-Nebout N, Evesque L, et al. Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial. Ann Oncol. 2024;35(10):873\u201181.","DOI":"10.1016\/j.annonc.2024.06.019"},{"key":"10.1016\/j.ctro.2026.101194_b0095","doi-asserted-by":"crossref","unstructured":"Arbea L, Ramos LI, Mart\u00ednez-Monge R, Moreno M, Aristu J. Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications. Radiat Oncol. 2010;5:17.","DOI":"10.1186\/1748-717X-5-17"},{"issue":"1","key":"10.1016\/j.ctro.2026.101194_b0100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s11605-016-3242-8","article-title":"Intensity-modulated radiation therapy is not associated with perioperative or survival benefit over 3D-conformal radiotherapy for rectal cancer","volume":"21","author":"Sun","year":"2017","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.ctro.2026.101194_b0105","doi-asserted-by":"crossref","unstructured":"Nuyttens JJ, Robertson JM, Yan D, Martinez A. The variability of the clinical target volume for rectal cancer due to internal organ motion during adjuvant treatment. Int J Radiat Oncol Biol Phys. 2002;53(2):497\u2011503.","DOI":"10.1016\/S0360-3016(02)02753-0"},{"issue":"2","key":"10.1016\/j.ctro.2026.101194_b0110","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.radonc.2009.04.022","article-title":"Target volume shape variation during hypo-fractionated preoperative irradiation of rectal cancer patients","volume":"92","author":"Nijkamp","year":"2009","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101194_b0115","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.radonc.2009.08.007","article-title":"Target volume shape variation during irradiation of rectal cancer patients in supine position: comparison with prone position","volume":"93","author":"Nijkamp","year":"2009","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101194_b0120","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.radonc.2011.11.011","article-title":"Repeat CT assessed CTV variation and PTV margins for short- and long-course pre-operative RT of rectal cancer","volume":"102","author":"Nijkamp","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101194_b0125","doi-asserted-by":"crossref","unstructured":"Brierley JD, Dawson LA, Sampson E, Bayley A, Scott S, Moseley JL, et al. Rectal motion in patients receiving preoperative radiotherapy for carcinoma of the rectum. Int J Radiat Oncol Biol Phys. 2011;80(1):97\u2011102.","DOI":"10.1016\/j.ijrobp.2010.01.042"},{"issue":"2","key":"10.1016\/j.ctro.2026.101194_b0130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.radonc.2016.07.017","article-title":"International consensus guidelines on clinical target volume delineation in rectal cancer","volume":"120","author":"Valentini","year":"2016","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2026.101194_b0135","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.clon.2011.07.012","article-title":"Image-guided radiotherapy for rectal cancer \u2014 a systematic review","volume":"24","author":"Gwynne","year":"2012","journal-title":"Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101194_b0140","article-title":"Bladder filling variation during conformal radiotherapy for rectal cancer","volume":"851","author":"Sithamparam","year":"2017","journal-title":"J Phys: Conf Ser"},{"issue":"8","key":"10.1016\/j.ctro.2026.101194_b0145","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1118\/1.1992207","article-title":"Reproducibility of the bladder shape and bladder shape changes during filling","volume":"32","author":"Lotz","year":"2005","journal-title":"Med Phys"},{"issue":"5","key":"10.1016\/j.ctro.2026.101194_b0150","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1111\/ajco.13603","article-title":"Bladder filling volume variation between the first and second day of planning computed tomography for prostate cancer radiation therapy and correlation with renal function","volume":"18","author":"Ishibashi","year":"2022","journal-title":"Asia Pac J Clin Oncol"},{"issue":"1\u20132","key":"10.1016\/j.ctro.2026.101194_b0155","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.canrad.2021.11.002","article-title":"Rectal cancer radiotherapy","volume":"26","author":"Vendrely","year":"2022","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ctro.2026.101194_b0160","unstructured":"ICRU Report 83, Prescribing, Recording, and Reporting Intensity-Modulated Photon-Beam Therapy (IMRT) \u2013 ICRU [Internet]. [cit\u00e9 29 f\u00e9vr 2024]. Disponible sur: https:\/\/www.icru.org\/report\/prescribing-recording-and-reporting-intensity-modulated-photon-beam-therapy-imrticru-report-83\/."},{"key":"10.1016\/j.ctro.2026.101194_b0165","doi-asserted-by":"crossref","unstructured":"Gay HA, Barthold HJ, O\u2019Meara E, Bosch WR, El Naqa I, Al-Lozi R, et al. Pelvic normal tissue contouring guidelines for radiation therapy: a radiation therapy oncology group consensus panel atlas. Int J Radiat Oncol Biol Phys. 2012;83(3):e353\u201162.","DOI":"10.1016\/j.ijrobp.2012.01.023"},{"key":"10.1016\/j.ctro.2026.101194_b0170","doi-asserted-by":"crossref","unstructured":"Kavanagh BD, Pan CC, Dawson LA, Das SK, Li XA, Ten Haken RK, et al. Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S101-107.","DOI":"10.1016\/j.ijrobp.2009.05.071"},{"key":"10.1016\/j.ctro.2026.101194_b0175","unstructured":"INCa: Recherche de d\u00e9ficit en dihydropyrimidine... - Google Scholar [Internet]. [cit\u00e9 12 juin 2024]."},{"key":"10.1016\/j.ctro.2026.101194_b0180","doi-asserted-by":"crossref","unstructured":"Santiago I, Figueiredo N, Par\u00e9s O, Matos C. MRI of rectal cancer\u2014relevant anatomy and staging key points. Insights into Imaging. 2020;11(1):100.","DOI":"10.1186\/s13244-020-00890-7"},{"key":"10.1016\/j.ctro.2026.101194_b0185","doi-asserted-by":"crossref","unstructured":"Nugent K, O\u2019Neill B, Brennan V, Lynch J, Higgins M, Dunne M, et al. Quantification of organ motion in male and female patients undergoing long-course radiation therapy for rectal cancer in the supine position. Adv Radiat Oncol. 2023;8(1):101109.","DOI":"10.1016\/j.adro.2022.101109"},{"issue":"1","key":"10.1016\/j.ctro.2026.101194_b0190","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3857\/roj.2013.31.1.41","article-title":"Bladder filling variations during concurrent chemotherapy and pelvic radiotherapy in rectal cancer patients: early experience of bladder volume assessment using ultrasound scanner","volume":"31","author":"Chang","year":"2013","journal-title":"Radiat Oncol J"},{"issue":"1","key":"10.1016\/j.ctro.2026.101194_b0195","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/nau.25294","article-title":"Normal postvoid residual urine in healthy adults","volume":"43","author":"Lim","year":"2024","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"10.1016\/j.ctro.2026.101194_b0200","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.radonc.2006.05.007","article-title":"Variability of bladder filling in patients receiving radical radiotherapy to the prostate","volume":"79","author":"O\u2019Doherty","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101194_b0205","doi-asserted-by":"crossref","unstructured":"Rokan Z, Simillis C, Kontovounisios C, Moran B, Tekkis P, Brown G. locally recurrent rectal cancer according to a standardized MRI classification system: a systematic review of the literature. J Clin Med. 2022;11(12):3511.","DOI":"10.3390\/jcm11123511"},{"key":"10.1016\/j.ctro.2026.101194_b0210","doi-asserted-by":"crossref","unstructured":"Viswanathan AN, Yorke ED, Marks LB, Eifel PJ, Shipley WU. Radiation dose-volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S116-122.","DOI":"10.1016\/j.ijrobp.2009.02.090"},{"key":"10.1016\/j.ctro.2026.101194_b0215","doi-asserted-by":"crossref","unstructured":"Boldrini L, Chiloiro G, Cusumano D, Romano A, Placidi L, Turco G, et al. Mesorectal motion evaluation in rectal cancer MR-guided radiotherapy: an exploratory study to quantify treatment margins. Radiat Oncol. 2023;18(1):4.","DOI":"10.1186\/s13014-022-02193-1"},{"key":"10.1016\/j.ctro.2026.101194_b0220","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.radonc.2021.07.011","article-title":"Planning target volume margin assessment for online adaptive MR-guided dose-escalation in rectal cancer on a 1.5 T MR-Linac","volume":"162","author":"Eijkelenkamp","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101194_b0225","doi-asserted-by":"crossref","unstructured":"Cox MC, Braam PM, R\u00fctten H, van Leeuwen R, Wendling M. Mesorectal shape variation in rectal cancer radiotherapy in prone position using a belly board. Phys Imaging Radiat Oncol. 2021;19:120\u20115.","DOI":"10.1016\/j.phro.2021.08.001"},{"key":"10.1016\/j.ctro.2026.101194_b0230","doi-asserted-by":"crossref","unstructured":"Wang W, Zhang Y, Gu Z, Zhang F, Wang C, Hu K, et al. Daily online adaptive radiotherapy for rectal cancer utilizing CT-Linac: assessing feasibility, toxicities and optimal margins. Int J Radiat Oncol Biol Phys. 2024;120(2):e595\u20116.","DOI":"10.1016\/j.ijrobp.2024.07.1312"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:41:02Z","timestamp":1783395662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826000893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":46,"alternative-id":["S2405630826000893"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101194","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MESORECT : Influence of bladder depletion on mesorectal movements during radiation therapy of locally advanced rectal cancers: a prospective comparative study","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101194"}}